06/06/2009Vicus Therapeutics Announces Participation at Cambridge Healthtech Institute’s Ninth Annual Beyond Genome Conference
...View press release

03/23/2009 Vicus Therapeutics’ Chief Executive Officer to Speak at Cambridge Healthtech Institute’s Inaugural Executive Summit on Strategy and Innovation ...View press release

11/07/2008Vicus Therapeutics to Participate in BIOTECH 2008 Expert Panels ...View press release

10/02/2008Vicus Therapeutics to Present at Cambridge Healthtech Institute’s Third Annual Drug Repositioning Summit ...View press release

08/15/2007Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA ...View press release

06/19/2007Vicus Therapeutics to Present Results from Investigator-led Cancer Cachexia Studies at the 12th Congress of the Japanese Society for Palliative Medicine ...View press release

02/28/2007Vicus Therapeutics Announces Participation at 14th International Molecular Medicine Tri-Conference ...View press release

01/16/2007Vicus Therapeutics Announces FDA Approval of Phase 2 Trial of VT-122 for the Treatment of Cachexia in Patients With Advanced Lung Cancer ...View press release

11/20/2006Vicus Therapeutics to Host Webinar on Repurposing Drugs to Create Proprietary Cancer Products ...View press release

10/16/2006Vicus Therapeutics Signs Strategic Services Agreement with Leading Indian Clinical Research Organization ...View press release